Ligand validation:6ZE2

FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

FDA is a Ligand Of Interest in 6ZE2 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZE2_FDA_B_701	99%	60%	0.048	0.979	0.71	0.83	-	1	3	0	100%	1
6ZE2_FDA_A_701	99%	58%	0.049	0.978	0.76	0.83	-	1	3	0	100%	1
7AA2_FDA_B_701	100%	55%	0.044	0.987	0.85	0.89	2	2	3	0	100%	1
6ZE6_FDA_A_701	100%	60%	0.044	0.984	0.72	0.8	-	1	3	0	100%	1
6ZE4_FDA_A_701	93%	58%	0.07	0.965	0.77	0.86	1	1	6	0	100%	1
6ZE7_FDA_A_701	91%	57%	0.073	0.96	0.78	0.87	-	3	4	0	100%	1
6ZE5_FDA_A_701	86%	62%	0.098	0.968	0.59	0.87	-	1	5	0	100%	1
4OPD_FDA_B_501	100%	67%	0.02	0.995	0.55	0.71	-	1	2	0	100%	1
3UKF_FDA_B_600	100%	10%	0.026	0.995	2.22	2.05	19	19	0	0	100%	1
3TSH_FDA_A_601	100%	38%	0.04	0.992	1.03	1.38	3	6	3	0	100%	1
4MOR_FDA_B_801	100%	15%	0.037	0.989	1.83	1.96	12	19	1	0	100%	1
4OPC_FDA_A_501	100%	64%	0.038	0.986	0.6	0.76	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.